Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/540937 stock hub

BOM/540937 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/540937is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.4B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/540937

In the news

Latest news · BOM/540937

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E29.7

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC13.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/540937 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

171

Groups with data

Currency

INR

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	213
Employees Change	20%
Employees Change Percent	10.36
Enterprise value	INR 3.6B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 3.4B
Price	INR 41.5
Price currency	INR
Rev Per Employee	8,961,164.32x
Sic	2834
Symbol	bom/540937
Website	https://medicoremedies.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.37%
EV Earnings	30.62x
EV/EBIT	26.34x
EV/EBITDA	21.46x
EV/Sales	1.86x
P/B ratio	5.15x
P/E ratio	29.71x
P/S ratio	1.8x
PE Ratio10 Y	39.26x
PE Ratio3 Y	56.75x
PE Ratio5 Y	49.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.06%
EBITDA Margin	8.45%
Gross margin	26.04%
Gross Profit	INR 497.1M
Gross Profit Growth	29.88%
Gross Profit Growth Q	34.6%
Gross Profit Growth3 Y	11.39%
Gross Profit Growth5 Y	12.21%
Net Income	INR 116M
Net Income Growth	31.04%
Net Income Growth Q	9.64%
Net Income Growth3 Y	15.57%
Net Income Growth5 Y	35.62%
Pretax Margin	8.09%
Profit Margin	6.08%
Profit Per Employee	INR 544,573
Roa5y	5.23
Roe5y	15.01
ROIC	13.05
Roic5y	10.22

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-22.04%
Cagr3y	-21.56%
Cagr5y	44.67%
EPS Growth	32.1
EPS Growth Q	9.38
EPS Growth3 Y	15.58
EPS Growth5 Y	35.59
Revenue Growth	26.44x
Revenue Growth Q	48.6x
Revenue Growth3 Y	9.67x
Revenue Growth5 Y	10.68x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 17.6M
Debt	INR 125.3M
Debt EBITDA	INR 0.76
Debt Equity	INR 0.19
Equity	INR 668.6M
Interest Coverage	12.34
Net Cash	INR -107.6M
Net Cash By Market Cap	INR -3.13
Net Debt EBITDA	INR 0.67
Net Debt Equity	INR 0.16
Tangible Book Value	INR 668.1M
Tangible Book Value Per Share	INR 8.06
WACC	7.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-22.02%
200-day SMA	45.16
3Y total return	-51.75%
50-day SMA	40.38
50-day SMA vs 200-day SMA	50under200
5Y total return	533.59%
All Time High	100.8
All Time High Change	-58.83%
All Time High Date	2023-05-31
All Time Low	3.35
All Time Low Change	1,138.81%
All Time Low Date	2020-07-13
ATR	1.93
Beta	0.56
Beta1y	0.53
Beta2y	0.34
Ch YTD	-17.92
High	43
High52	59
High52 Date	2025-05-29
High52ch	-29.66%
Low	41.5
Low52	31
Low52 Date	2026-03-30
Low52ch	33.87%
Ma50ch	2.77%
Price vs 200-day SMA	-8.11%
RSI	53.31
RSI Monthly	45.41
RSI Weekly	44.68
Sharpe ratio	-0.34x
Sortino ratio	-0.4
Total Return	0.8%
Tr YTD	-17.92
Tr1m	4.67%
Tr1w	-2.26%
Tr3m	-12.83%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 134.8M
Operating Income Growth	35.08
Operating Income Growth Q	50.78
Operating Income Growth3 Y	29.9
Operating Income Growth5 Y	32.97
Operating margin	7.06

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,044,610%
Shares Insiders	74.96%
Shares Institutions	1.2%
Shares Out	82,984,000
Shares Qo Q	-0.94%
Shares Yo Y	-0.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	9,682.85x
Bv Per Share	8.07
Ch1m	4.67
Ch1w	-2.26
Ch1y	-22.02
Ch3m	-12.83
Ch3y	-51.75
Ch5y	533.6
Ch6m	-16.92
Change	-1.07%
Change From Open	-3.49
Close	41.95
Days Gap	2.5
Depreciation Amortization	26,474,250
Dollar Volume	40,338
Earnings Date	2026-05-30
EBIT	INR 134.8M
EBITDA	INR 161.3M
EPS	INR 1.4
F Score	2
Fiscal Year End	March
Founded	1,994
Graham Number	15.92677
Graham Upside	-61.62
Income Tax	INR 38.4M
Is Primary Listing	1
Last Earnings Date	2026-02-12
Last Report Date	2025-12-31
Last Split Date	2023-03-16
Last Split Type	Forward
Lynch Fair Value	INR 34.92
Lynch Upside	-15.84
Ma150	46.8
Ma150ch	-11.32%
Ma20	40.77
Ma20ch	1.8%
Next Earnings Date	2026-05-30
Open	43
Position In Range	0
Price Date	2026-05-08
Price EBITDA	INR 21.35
Ptbv Ratio	5.15
Relative Volume	0.1x
Revenue	1,908,728,000x
Tax By Revenue	2.01x
Tax Rate	24.87%
Tr6m	-16.92%
Volume	972

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/540937 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/540937 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/540937?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.2%

Share of float held by funds and institutions

Insider ownership

+75.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.8%

Negative means the company is buying back shares.

Technical

BOM/540937 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.3

Neutral momentum band

Price vs 200-day MA

-8.1%

50/200-day relationship not available

Beta (5Y)

0.56

Less volatile than the market

Sharpe ratio

-0.34

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/540937

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/540937 stock rating?

bom/540937 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/540937 analysis?

The full report lives at /stocks/bom/540937/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/540937?

The latest report frames bom/540937 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/540937 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.